CompletedPhase 2NCT02060474
Thyroid Hormone Analog Therapy in MCT8 Deficiency: Triac Trial Patients
Studying Allan-Herndon-Dudley syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Erasmus Medical Center
- Principal Investigator
- W.E. Visser, dr,Erasmus Medical Center
- Intervention
- Triac(drug)
- Enrollment
- 46 enrolled
- Eligibility
- 99 years · MALE
- Timeline
- 2014 – 2018
Study locations (1)
- Erasmus Medical Center, Rotterdam, South Holland, Netherlands
Collaborators
ZonMw: The Netherlands Organisation for Health Research and Development
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02060474 on ClinicalTrials.govOther trials for Allan-Herndon-Dudley syndrome
Additional recruiting or active studies for the same condition.